Results 231 to 240 of about 298,517 (337)

Immunoglobulin therapies for primary immunodeficiency diseases (part 2): considerations for dosing strategies. [PDF]

Immunotherapy
Li Z, Mahmood I.
europepmc   +1 more source

CD5 B-Cell Predominant Primary Immunodeficiency: Part of the Spectrum of MAGT1 Deficiency. [PDF]

Ther Adv Allergy Rhinol, 2023
Rowane MJ, Stewart-Bates BC, Doll RJ, Meyerson HJ, Venglarcik JS, Callahan M, Fill L, Saab R, Ochs HD, Hostoffer RW.   +9 more
europepmc   +1 more source

Primary Immunodeficiency

, 2020
openaire   +3 more sources

Discovery of miRNAs unique to actively transcribed erythroparvovirus infection in heart failure patients

ESC Heart Failure, EarlyView.
Abstract Aims miRNAs, small non‐coding RNAs, play key roles in gene regulation, cell differentiation and tissue development. They influence viral infection outcomes by directly interacting with viral genomes or modifying the host microenvironment. This study demonstrates miRNAs' ability to selectively suppress transcriptionally active erythroparvovirus,
Ganna Aleshcheva, Sara Salih, Christian Baumeier, Felicitas Escher, C. Thomas Bock, Heinz‐Peter Schultheiss   +5 more
wiley   +1 more source

Psychosocial Evaluation of Adults with Primary Immunodeficiency. [PDF]

J Clin Immunol
Gumusburun R, Altay S, Cengiz H, Hakverdioglu Yont G, Kuman Tuncel O, Ardeniz O.   +5 more
europepmc   +1 more source

The risk of death according to left ventricular ejection fraction and right ventricular dilatation in 17 321 adults with heart failure from 40 high‐, middle‐ and low‐income countries – A Global Congestive Heart Failure (G‐CHF) study

European Journal of Heart Failure, EarlyView.
Abstract Aims The aim of this study was to describe the prognostic importance of left ventricular ejection fraction (LVEF) versus right ventricular (RV) dilatation and dysfunction in patients with heart failure (HF) from countries of different income levels. Methods and results We enrolled 17 321 participants with HF from 40 countries.
Darryl P. Leong, Philip G. Joseph, Hisham Dokainish, Stefan Störk, John V.V. McMurray, Lisa M. Mielniczuk, Sanjib Kumar Sharma, Andrés Orlandini, Kamilu M. Karaye, Antoni Bayes‐Genis, Tara McCready, Alex Grinvalds, Kumar Balasubramanian, Kelley R. Branch, Kristian Kragholm, Salim Yusuf, on behalf of the G‐CHF Investigators   +16 more
wiley   +1 more source

Albinism and Primary Immunodeficiency in Infants: A Case Study of Griscelli Syndrome. [PDF]

Cureus
Bouhafs N, N'joumi C, Elouali A, Babakhouya A, Rkain M, Benajiba N.   +5 more
europepmc   +1 more source

The Orphan Seven-Transmembrane Receptor Apj Supports the Entry of Primary T-Cell-Line-Tropic and Dualtropic Human Immunodeficiency Virus Type 1

, 1998
Hyeryun Choe, Michael Farzan, Miriam K. Konkel, Kathleen A. Martin, Ying Sun, Luisa Marcon, Mark J. Cayabyab, Michael A. Berman, Martin E. Dorf, Norma P. Gerard, Craig Gérard, Joseph Sodroski   +11 more
openalex   +1 more source

Antiretroviral Therapy during Primary Immunodeficiency Virus Infection Can Induce Persistent Suppression of Virus Load and Protection from Heterologous Challenge in Rhesus Macaques [PDF]

, 2000
Brigitte Rosenwirth, Peter ten Haaft, Willy Bogers, Ivonne G. Nieuwenhuis, Henk Niphuis, Eva-Maria Kuhn, Norbert Bischofberger, Jonathan L. Heeney, Klaus Überla   +8 more
openalex   +1 more source

Update on preclinical models of cancer therapy‐related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio‐Oncology, and the ESC Working Group on Cellular Biology of the Heart

European Journal of Heart Failure, EarlyView.
New anticancer therapies with potential cardiovascular side effects are continuously being introduced into clinical practice, with new and often unexpected toxicities becoming apparent only after clinical introduction. These unknown toxicities should be identified and understood beforehand to better prepare patients and physicians, enabling the ...
Alessandra Ghigo, Pietro Ameri, Aarti Asnani, Edoardo Bertero, Rudolf A. de Boer, Dimitrios Farmakis, Arantxa González, Stephane Heymans, Borja Ibáñez, Teresa López‐Fernández, Alexander R. Lyon, Piero Pollesello, Amina Rakisheva, Konstantinos Stellos, Katrin Streckfuss‐Bömeke, Carlo Gabriele Tocchetti, Thomas Thum, Peter van der Meer, Eva Van Rooij, Piotr Ponikowski, Marco Metra, Giuseppe Rosano, Sophie Van Linthout   +22 more
wiley   +1 more source